(19)
(11) EP 3 687 510 A1

(12)

(43) Date of publication:
05.08.2020 Bulletin 2020/32

(21) Application number: 18786593.6

(22) Date of filing: 27.09.2018
(51) International Patent Classification (IPC): 
A61K 9/70(2006.01)
A61K 31/085(2006.01)
(86) International application number:
PCT/US2018/053042
(87) International publication number:
WO 2019/067670 (04.04.2019 Gazette 2019/14)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 27.09.2017 US 201715717859
23.10.2017 US 201715791249

(71) Applicant: Aquestive Therapeutics, Inc.
Warren, NJ 07059 (US)

(72) Inventors:
  • SCHOBEL, Alexander, Mark
    Whitehouse Station NJ 08889 (US)
  • VARJAN, Stephanie, Marie
    Oradell NJ 07649 (US)
  • WARGACKI, Stephen, Paul
    Annandale NJ 08801 (US)

(74) Representative: D Young & Co LLP 
120 Holborn
London EC1N 2DY
London EC1N 2DY (GB)

   


(54) ENHANCED DELIVERY EPINEPHRINE AND PRODRUG COMPOSITIONS